Cargando…

Clinical characteristics of Leucine-rich glioma-inactivated protein 1 antibody-mediated autoimmune encephalitis in a 6-year-old girl: case report and literature reviews

BACKGROUND: Autoimmune encephalitis related to the leucine-rich glioma-inactivated protein 1(LGI1) antibody is the most prevalent in older adults, manifesting as seizures, faciobrachial dystonic seizures (FBDS), cognitive impairment, memory disturbance, hyponatremia and neuropsychiatric disorders. H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Liqing, Su, Tangfeng, Liu, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311720/ https://www.ncbi.nlm.nih.gov/pubmed/37391712 http://dx.doi.org/10.1186/s12883-023-03299-z

Ejemplares similares

Limbic encephalitis associated with leucine-rich glioma-inactivated 1 antibodies
por: Messelmani, Mariem, et al.
Publicado: (2015)

Leucine-rich glioma-inactivated protein 1 antibody-associated encephalitis in a 22-month-old girl: a case report
por: Zhao, JiaChang, et al.
Publicado: (2023)

Leucine-Rich Glioma-Inactivated 1 Encephalitis: Broadening the Sphere
por: Rachdi, Amine, et al.
Publicado: (2019)

Leucine-rich glioma-inactivated protein 1 antibody encephalitis: A case report
por: Mayasi, Yunis, et al.
Publicado: (2014)

The First Case of Familiar Anti-leucine-rich Glioma-Inactivated1 Autoimmune Encephalitis: A Case Report and Literature Review
por: Ding, Chuhan, et al.
Publicado: (2022)

Anti-leucine-rich Glioma Inactivated-1 Encephalitis Associated with Essential Thrombocythemia
por: Yuan, Xiaoling, et al.
Publicado: (2020)

Residual Fatigue and Cognitive Deficits in Patients After Leucine-Rich Glioma-Inactivated 1 Antibody Encephalitis
por: Binks, Sophie N. M., et al.
Publicado: (2021)

Anti-leucine-rich glioma-inactivated 1 encephalitis: two case reports and a review of the literature
por: Karvigh, Sanaz Ahmadi, et al.
Publicado: (2022)

Cortical metabolic characteristics of anti-leucine-rich glioma-inactivated 1 antibody encephalitis based on (18)F-FDG PET
por: Wang, Kai, et al.
Publicado: (2023)

Clinical analysis of leucine-rich glioma inactivated-1 protein antibody associated with limbic encephalitis onset with seizures
por: Li, Zhimei, et al.
Publicado: (2016)

Motor Phenomena Associated With Leucine-Rich Glioma-Inactivated (LGI1) Emi-Encephalitis
por: Giorelli, Maurizio, et al.
Publicado: (2023)

COVID-19-Vaccine-Pfizer-BioNTech: Anti-leucine rich glioma inactivated 1 autoimmune encephalitis: case report
Publicado: (2022)

Leucine-rich Glioma-inactivated 1 Encephalitis Followed by Isaacs Syndrome: Alternating Presence of Pathogenic Autoantibodies to Leucine-rich Glioma-inactivated 1 and Contactin-associated Protein-like 2
por: Murayama, Aki, et al.
Publicado: (2022)

Serial assessment of multimodality imaging in anti-leucine-rich glioma-inactivated 1 antibody encephalitis: A case report
por: Wada, Takafumi, et al.
Publicado: (2022)

A case of leucine-rich glioma-inactivated 1 antibody encephalitis with schizophrenia-like symptoms as an initial clinical manifestation
por: Moon, Jiyeon, et al.
Publicado: (2022)

Reversible Bilateral Striatal Hypermetabolism in a Patient with Leucine-Rich Glioma Inactivated-1 Encephalitis
por: Takkar, Aastha, et al.
Publicado: (2016)

Antiepileptic drug therapy in autoimmune epilepsy associated with antibodies targeting the leucine‐rich glioma‐inactivated protein 1
por: Feyissa, Anteneh M., et al.
Publicado: (2018)

Discrimination between leucine-rich glioma-inactivated 1 antibody encephalitis and gamma-aminobutyric acid B receptor antibody encephalitis based on ResNet18
por: Pan, Jian, et al.
Publicado: (2023)

Leucine-Rich Glioma Inactivated-1 and Voltage-Gated Potassium Channel Autoimmune Encephalitis Associated with Ischemic Stroke: A Case Report
por: McGinley, Marisa, et al.
Publicado: (2016)

CXCL13 Is A Biomarker Of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients
por: Lin, You-ting, et al.
Publicado: (2019)

Arterial Spin Labeling Imaging Characteristics of Anti-leucine-rich Glioma-Inactivated 1 Encephalitis: A Qualitative and Quantitative Analysis
por: Yedavalli, Vivek Srikar, et al.
Publicado: (2022)

Leucine-Rich Glioma-Inactivated Protein 1 Antibody-Positive Limbic Encephalitis in a Patient with Adenocarcinoma of Prostate: A Case Report
por: Navalli, Devaraddi, et al.
Publicado: (2019)

Anti-leucine-rich glioma inactivated protein 1 encephalitis with sleep disturbance as the first symptom: A case report and review of literature
por: Kong, De-Lian
Publicado: (2023)

CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Letter]
por: Wei, Mingyu, et al.
Publicado: (2020)

Telemedicine assessment of long-term cognitive and functional status in anti-leucine-rich, glioma-inactivated 1 encephalitis
por: Sola-Valls, Nuria, et al.
Publicado: (2019)

Clinical Features and Therapeutic Effects of Anti-leucine-rich Glioma Inactivated 1 Encephalitis: A Systematic Review
por: Teng, Yuou, et al.
Publicado: (2022)

Persistent hiccup as one of the initial symptoms of leucine-rich glioma-inactivated-1 encephalitis: a case report
por: Hou, Lan, et al.
Publicado: (2022)

Subcortical Hypermetabolism Associated With Cortical Hypometabolism Is a Common Metabolic Pattern in Patients With Anti-Leucine-Rich Glioma-Inactivated 1 Antibody Encephalitis
por: Zhao, Xiaobin, et al.
Publicado: (2021)

Anti-leucine-rich Glioma-inactivated-1 Encephalitis with Faciobrachial Dystonic Seizures and Behavioral Problems: A Case Report
por: Adhikari, Ayush, et al.
Publicado: (2020)

CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Response to Letter]
por: Wang, Sheng-jun, et al.
Publicado: (2020)

Clinical Features and Gut Microbial Alterations in Anti-leucine-rich Glioma-Inactivated 1 Encephalitis—A Pilot Study
por: Ma, Xueying, et al.
Publicado: (2020)

CHI3L1 in the CSF is a potential biomarker for anti-leucine-rich glioma inactivated 1 encephalitis
por: Li, Jinyi, et al.
Publicado: (2023)

Brain Magnetic Resonance Imaging Characteristics of Anti-Leucine-Rich Glioma-Inactivated 1 Encephalitis and Their Clinical Relevance: A Single-Center Study in China
por: Shao, Xiali, et al.
Publicado: (2021)

A Psychiatric Side Effect of Levetiracetam Can Mimic a Relapse of Anti-Leucine-Rich Glioma Inactivated 1 Encephalitis
por: Jang, Yoonhyuk, et al.
Publicado: (2018)

Clinical Features and Long-Term Outcomes of Anti-Leucine-Rich Glioma-Inactivated 1 Encephalitis: A Multi-Center Study
por: Qiao, Shan, et al.
Publicado: (2021)

Abnormal DNA methylation analysis of leucine-rich glioma-inactivated 1 antibody encephalitis reveals novel methylation-driven genes related to prognostic and clinical features
por: Qiao, Shan, et al.
Publicado: (2023)

Leucine-rich glioma inactivated 3: integrative analyses support its prognostic role in glioma
por: Kwon, Nyoun Soo, et al.
Publicado: (2017)

Anti-Leucine-Rich Glioma-Inactivated 1 (Anti-LGI 1) Limbic Encephalitis and New-Onset Psychosis: A Case Report
por: Alho, António, et al.
Publicado: (2023)

Leucine-Rich Glioma-Inactivated Protein 1 Antibody-Positive Polyradiculopathy Associated with Epstein-Barr Virus Infection
por: Uzunalimoğlu, Berrin Pelit, et al.
Publicado: (2021)

A case of autoimmune epilepsy associated with anti-leucine-rich glioma inactivated subunit 1 antibodies manifesting electrical shock-like sensations and transparent sadness
por: Murata, Yoshiko, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_57omr44el5e8m8eorrctk3uahp